Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Jon Summers at [email protected].

  • May 11, 2023

    Patients and Caregivers Now Have Option for Treating Alzheimer’s-Related Agitation

    Alzheimer’s patients, caregivers, and advocates are applauding the decision by the Food...

    Read more
  • May 03, 2023

    More Promising News for People Living with Alzheimer's

    Patients Cheer Phase 3 clinical trials showing new drug slows decline compared...

    Read more
  • April 24, 2023

    Brain Health Academy Enrollment is Now Open, First Session Launches May 17

    Free continuing education program for health and wellness professionals adds six new...

    Read more
  • April 14, 2023

    UsAgainstAlzheimer’s Letter to Becerra: Your Inaccurate Statements to the Senate Must Be Corrected

    In a letter sent today to Health and Human Services Secretary Xavier...

    Read more
  • March 13, 2023

    Veterans Affairs Decision to Cover Leqembi Should Serve as Model for Federal Regulators

    UsAgainstAlzheimer’s chair and co-founder George Vradenburg issued the following statement in response...

    Read more
  • February 27, 2023

    Statement on the Retirement of Dr. Billy Dunn

    UsAgainstAlzheimer’s chair and co-founder George Vradenburg issued the following statement regarding the...

    Read more
  • February 23, 2023

    CMS Slams the Door on Alzheimer’s Patients – Again

    UsAgainstAlzheimer’s chair and co-founder George Vradenburg issued the following statement in response...

    Read more
  • January 31, 2023

    Senator Collins, Bipartisan Colleagues Introduce Bills to Bolster Alzheimer’s Research

    Senators Susan Collins (R-ME), Mark Warner (D-VA), Shelley Moore Capito...

    Read more
  • January 20, 2023

    UsAgainstAlzheimer’s Statement on FDA Complete Response Letter for Donanemab

    Washington, D.C. (January 19, 2023) – UsAgainstAlzheimer’s chief operating officer Russ Paulsen issued...

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.

Read Report